III Earnings

III reported its FY2025Q3 earnings on 2025-11-03, showcasing a revenue of 62.00M against an estimate of 61.00M, resulting in a 2.34% surprise. The EPS was 0.07, surpassing the expected 0.08 by -12.5% . The stock experienced a 10.16% price change on the earnings day and a 5.08% change over the next five days, reflecting market reactions to the results.

Following III's FY2025Q3 earnings announcement on 2025-11-03, the stock price moved by 10.16% on the day of the release. Over the subsequent five days, it saw a 5.08% change. Historically, III's stock price tends to shift by an average of +0.13% in the 10 days leading up to earnings and +2.64% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate III’s annual revenue to reach 61.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.61% and EPS estimates Revise Upward by 0.63% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between III's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.61%, while EPS estimates moved Revise Upward by 0.63% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, III's stock price typically moves by +0.13% in the 10 days before its earnings and +2.64% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 61.00M.

The earnings call highlights strong growth potential, particularly in AI and public sector markets, and successful integration of acquisitions. Despite cautious macroeconomic sentiment, industries like consumer and energy show promise. The flat labor market is strategic, not due to difficulties. However, some responses were vague, especially regarding APAC recovery timelines and acquisition valuations. Overall, the positive elements outweigh the negatives, suggesting a stock price increase in the short term.